Session organised by AstraZeneca, La Roche-Posay, Pfizer, Roche, Union for International Cancer Control
Chaired by Ulrika Årehed Kågström, President-elect, Union for International Cancer Control (UICC) (Sweden)
Presentations: 1. Panelist input - Suneet Varma, Pfizer (United States)
2. Panelist input - Michael Oberreiter, Roche (Switzerland)
3. Panelist input - Maxime Dupont, La Roche Posay (France)
4. Panelist input - Sunil Verma, AstraZeneca (United States)